Insider Trading History of Chari Ravi S.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Chari Ravi S. since 2015. The trader's CIK number is 1632795. At the time of the last reporting, Chari Ravi S. was the SVP-Clinical Excellence of Hca Healthcare, Inc.. (stock ticker symbol HCA). Also see all insider trading activities at Hca Healthcare, Inc..


Yearly summary of insider trading at Hca Healthcare, Inc. (HCA) by Chari Ravi S.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 HCA 0 $0 16,270 $1,662,655 16,280 $830,456
2017 HCA 0 $0 47,857 $4,179,922 75,520 $2,409,654
2016 HCA 0 $0 0 $0 1,676 $0
2015 HCA 0 $0 11,166 $1,013,649 12,840 $108,165


Insider trading of Hca Healthcare, Inc. (HCA) by Chari Ravi S.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-02-25 HCA Option Ex 930 .00 0
2018-02-05 HCA Option Ex 500 .00 0
2018-01-31 HCA Option Ex 14,850 55.92 830,456
2018-02-01 HCA Sale 10,568 102.29 1,081,000
2018-02-02 HCA Sale 5,702 102.01 581,655
2017-03-27 HCA Option Ex 31,956 16.54 528,392
2017-03-27 HCA Sale 31,956 90.00 2,876,040
2017-02-05 HCA Option Ex 500 .00 0
2017-02-06 HCA Option Ex 564 .00 0
2017-02-01 HCA Sale 15,901 82.00 1,303,882
2017-01-17 HCA Option Ex 42,500 44.27 1,881,262
2016-02-08 HCA Option Ex 614 .00 0
2016-02-05 HCA Option Ex 500 .00 0
2016-02-06 HCA Option Ex 562 .00 0
2015-08-06 HCA Sale 11,166 90.78 1,013,649
2015-08-06 HCA Option Ex 11,166 9.69 108,165
2015-02-06 HCA Option Ex 562 .00 0
2015-02-08 HCA Option Ex 612 .00 0
2015-02-05 HCA Option Ex 500 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chari Ravi S. (SVP-Clinical Excellence of Hca Healthcare, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.